BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dembiński A, Warzecha Z, Ceranowicz P, Dembiński M, Cieszkowski J, Gosiewski T, Bulanda M, Kuśnierz-Cabala B, Gałązka K, Konturek PC. Synergic Interaction of Rifaximin and Mutaflor (Escherichia coli Nissle 1917) in the Treatment of Acetic Acid-Induced Colitis in Rats. Gastroenterol Res Pract 2016;2016:3126280. [PMID: 27433160 DOI: 10.1155/2016/3126280] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhou J, Shrestha P, Qiu Z, Harman DG, Teoh WC, Al-Sohaily S, Liem H, Turner I, Ho V. Distinct Microbiota Dysbiosis in Patients with Non-Erosive Reflux Disease and Esophageal Adenocarcinoma. J Clin Med. 2020;9. [PMID: 32650561 DOI: 10.3390/jcm9072162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Morsy MA, Khalaf HM, Rifaai RA, Bayoumi AMA, Khalifa EMMA, Ibrahim YF. Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2. Biomed Pharmacother 2021;141:111902. [PMID: 34328119 DOI: 10.1016/j.biopha.2021.111902] [Reference Citation Analysis]
3 Soleimanpour S, Hasanian SM, Avan A, Yaghoubi A, Khazaei M. Bacteriotherapy in gastrointestinal cancer. Life Sci 2020;254:117754. [PMID: 32389833 DOI: 10.1016/j.lfs.2020.117754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Khan AA, Alsahli MA, Rahmani AH. Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives. Med Sci (Basel) 2018;6:E33. [PMID: 29669993 DOI: 10.3390/medsci6020033] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 13.5] [Reference Citation Analysis]
5 Li S, Zhu X, Xing M. A New β-Galactosidase from the Antarctic Bacterium Alteromonas sp. ANT48 and Its Potential in Formation of Prebiotic Galacto-Oligosaccharides. Mar Drugs 2019;17:E599. [PMID: 31652852 DOI: 10.3390/md17110599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Ahmed O, Abdel-Halim M, Farid A, Elamir A. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats. Chem Biol Interact 2022;351:109715. [PMID: 34695389 DOI: 10.1016/j.cbi.2021.109715] [Reference Citation Analysis]
7 Hsieh TH, Kuo CW, Hsieh KH, Shieh MJ, Peng CW, Chen YC, Chang YL, Huang YZ, Chen CC, Chang PK, Chen KY, Chen HY. Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease. Brain Sci 2020;10:E206. [PMID: 32244769 DOI: 10.3390/brainsci10040206] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
8 Shang Q, Wang Y, Pan L, Niu Q, Li C, Jiang H, Cai C, Hao J, Li G, Yu G. Dietary Polysaccharide from Enteromorpha Clathrata Modulates Gut Microbiota and Promotes the Growth of Akkermansia muciniphila, Bifidobacterium spp. and Lactobacillus spp. Mar Drugs 2018;16:E167. [PMID: 29772753 DOI: 10.3390/md16050167] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
9 Caputi V, Giron MC. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease. Int J Mol Sci. 2018;19. [PMID: 29882798 DOI: 10.3390/ijms19061689] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 26.8] [Reference Citation Analysis]
10 Iida H, Tohno M, Islam MA, Sato N, Kobayashi H, Albarracin L, Kober AH, Ikeda-Ohtsubo W, Suda Y, Aso H, Nochi T, Miyazaki A, Uenishi H, Iwabuchi N, Xiao JZ, Villena J, Kitazawa H. Paraimmunobiotic Bifidobacteria Modulate the Expression Patterns of Peptidoglycan Recognition Proteins in Porcine Intestinal Epitheliocytes and Antigen Presenting Cells. Cells 2019;8:E891. [PMID: 31416116 DOI: 10.3390/cells8080891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Fouad MR, Salama RM, Zaki HF, El-Sahar AE. Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Int Immunopharmacol 2021;92:107354. [PMID: 33434756 DOI: 10.1016/j.intimp.2020.107354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chauhan V, Kanwar SS. Lipopeptide(s) associated with human microbiome as potent cancer drug. Semin Cancer Biol 2021;70:128-33. [PMID: 32574814 DOI: 10.1016/j.semcancer.2020.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ginter G, Ceranowicz P, Warzecha Z. Protective and Healing Effects of Ghrelin and Risk of Cancer in the Digestive System. Int J Mol Sci 2021;22:10571. [PMID: 34638910 DOI: 10.3390/ijms221910571] [Reference Citation Analysis]
14 Chen YJ, Chu WY, Yu WH, Chen CJ, Chia ST, Wang JN, Lin YC, Wei YJ. Massive Gastric Hemorrhage after Indomethacin Therapy: A Rare Presentation and Critical Management in an Extremely Preterm Infant. Children (Basel) 2021;8:545. [PMID: 34202886 DOI: 10.3390/children8070545] [Reference Citation Analysis]
15 Zatorski H, Salaga M, Zielińska M, Mokrowiecka A, Jacenik D, Krajewska WM, Małecka-Panas E, Fichna J. Colonic inflammation induces changes in glucose levels through modulation of incretin system. Pharmacol Rep 2021;73:1670-9. [PMID: 34535873 DOI: 10.1007/s43440-021-00327-y] [Reference Citation Analysis]
16 Behrouzi A, Mazaheri H, Falsafi S, Tavassol ZH, Moshiri A, Siadat SD. Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV. J Diabetes Metab Disord. 2020;19:597-604. [PMID: 32550212 DOI: 10.1007/s40200-020-00511-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M. Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers (Basel) 2019;11:E38. [PMID: 30609850 DOI: 10.3390/cancers11010038] [Cited by in Crossref: 143] [Cited by in F6Publishing: 129] [Article Influence: 47.7] [Reference Citation Analysis]
18 Xu J, Xia K, Li P, Qian C, Li Y, Liang X. Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917. Appl Microbiol Biotechnol 2020;104:6731-47. [PMID: 32535695 DOI: 10.1007/s00253-020-10733-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Adakudugu EA, Ameyaw EO, Obese E, Biney RP, Henneh IT, Aidoo DB, Oge EN, Attah IY, Obiri DD. Protective effect of bergapten in acetic acid-induced colitis in rats. Heliyon 2020;6:e04710. [PMID: 32885074 DOI: 10.1016/j.heliyon.2020.e04710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Li P, Hao Z, Liu H, Zhu B, Dang L, Ma C, Xu Y, Zhang Y, Fan D, Sun S. Quantitative Proteomics Analysis of Berberine-Treated Colon Cancer Cells Reveals Potential Therapy Targets. Biology (Basel) 2021;10:250. [PMID: 33806918 DOI: 10.3390/biology10030250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]